ANGELIA SIDARTA

Allopathic & Osteopathic Physicians|Family Medicine BREA, CA NPI 1790731776

General Payments — all program years on this page

$5,478.30

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 239
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $1,175.78 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $1,175.7820

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Acerta Pharma LLC $371.373
GlaxoSmithKline, LLC. $261.223
Lilly USA, LLC $258.777
IBSA Pharma Inc. $125.001
Novo Nordisk AS $97.794
Merck Sharp & Dohme Corporation $33.841
Lundbeck LLC $27.791

By program year

Program yearAmountRecords
2018 $1,663.1582
2019 $1,968.61113
2020 $381.7819
2021 $31.482
2022 $13.021
2023 $244.482
2024 $1,175.7820

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096572428 Novo Nordisk Inc $21.06 07/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096889610 Novo Nordisk Inc $24.59 04/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097096193 Novo Nordisk Inc $25.00 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097425709 Novo Nordisk Inc $27.14 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104387839 AstraZeneca Pharmaceuticals LP $121.37 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104423369 AstraZeneca Pharmaceuticals LP $125.00 06/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105833261 AstraZeneca Pharmaceuticals LP $125.00 10/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116486645 GlaxoSmithKline, LLC. $121.37 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116550583 GlaxoSmithKline, LLC. $125.00 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116725420 GlaxoSmithKline, LLC. $14.85 02/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135999183 Lilly USA, LLC $21.10 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135999185 Lilly USA, LLC $29.75 01/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136039255 Lilly USA, LLC $14.65 10/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136053500 Lilly USA, LLC $22.90 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136053502 Lilly USA, LLC $22.72 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136053504 Lilly USA, LLC $124.88 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136053506 Lilly USA, LLC $22.77 07/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141646704 Merck Sharp & Dohme LLC $33.84 07/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142977206 IBSA Pharma Inc. $125.00 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145969298 Lundbeck LLC $27.79 08/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.